Co-Targeting of Bcl-2 and mTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic Leukemia

McCubrey, James A.2022-02-042022-02-042015-09-16http://hdl.handle.net/10342/9648en-USsynergistic apoptosisacute lymphoblastic leukemiatargeted therapiesCo-Targeting of Bcl-2 and mTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic LeukemiaArticle